Top Anti Cancer Imported Medicine Drugs in India - Pharma Five

Pharma Five is a registered firm based in India. We specialize in Named Patient Imports, Imported cancer drugs, Imported medicines in india.

Contact Us Pharma Five Door No. 74, Old No. 26, Fagun Mansion, 3rd Floor, Ethiraj Salai, Egmore, Chennai - 600008 +916374297988 info@pharmafive.org
Buy Tecvayli (Teclistamab) Medicine in India

Tecvayli (Teclistamab)

Medicine name : Tecvayli

Generic name : Teclistamab

Manufactured By : Johnson & Johnson (Janssen)

Indications : Monotherapy for adults with relapsed or refractory multiple myeloma following at least one prior line of therapy.

Medicine Description : A bispecific antibody therapy for adults with relapsed or refractory multiple myeloma. Tecvayli (Teclistamab) binds to BCMA on myeloma cells and CD3 on T cells, helping the immune system recognise and destroy cancer cells.

Product Introduction

Tecvayli (Teclistamab) is a prescription immunotherapy medicine used to treat adults with relapsed or refractory multiple myeloma, a type of blood cancer that develops from plasma cells. It is a bispecific antibody that targets B-cell maturation antigen (BCMA) on myeloma cells and CD3 on T cells, helping the body's immune system recognise and destroy cancer cells.

Tecvayli is administered as a subcutaneous injection under the supervision of a qualified healthcare professional. Treatment begins with a step-up dosing schedule to reduce the risk of cytokine release syndrome (CRS). Patients require close monitoring, particularly during the initial doses, because serious immune-related reactions and neurological complications can occur.

Common side effects may include cytokine release syndrome, low blood cell counts, infections, fatigue, fever, nausea, diarrhoea and headache. Serious risks include severe infections, neurological toxicity, immune effector cell-associated neurotoxicity syndrome (ICANS) and potentially life-threatening immune reactions. Regular medical monitoring is essential throughout treatment.

Uses Of Tecvayli (Teclistamab)

Treatment of Relapsed or Refractory Multiple Myeloma

Benefits Of Tecvayli

Used to treat adults with multiple myeloma that has returned (relapsed) or has not responded to previous treatment (refractory). Tecvayli may be used as monotherapy in eligible patients or in combination with daratumumab, depending on the approved indication and treatment history.

Side Effects Of Tecvayli (Teclistamab)

Tecvayli (Teclistamab) may cause side effects during treatment. Their severity can vary depending on the patient's health and individual response to the medicine.

Common Side Effects of Tecvayli (Teclistamab)

  • Fever
  • Cytokine release syndrome (CRS)
  • Muscle, joint and bone pain
  • Injection site reactions
  • Fatigue and weakness
  • Upper respiratory tract infections
  • Nausea
  • Headache
  • Pneumonia
  • Diarrhoea
How To Use Tecvayli

Tecvayli is administered as a subcutaneous injection (under the skin) by a qualified healthcare professional. Treatment begins with a step-up dosing schedule of 0.06 mg/kg on Day 1, 0.3 mg/kg on Day 4 and 1.5 mg/kg on Day 7. Thereafter, the usual monotherapy dose is 1.5 mg/kg once weekly. For patients who achieve and maintain a complete response or better for at least 6 months, the dosing frequency may be reduced to once every two weeks. Patients require close monitoring during initial doses because of the risk of cytokine release syndrome and neurological toxicity.

How Tecvayli (Teclistamab) Works

Tecvayli is a bispecific antibody that binds to two proteins: BCMA on multiple myeloma cells and CD3 on T cells. By bringing these cells together, it activates T cells to recognise and destroy the cancer cells. This helps the immune system target and eliminate multiple myeloma cells.

Storage Conditions
  • Store Tecvayli injection in a refrigerator at 2°C to 8°C.
  • Keep the medicine in its original carton to protect it from light.
  • Do not freeze or shake the medicine.
  • Keep the injection in its original packaging until use and follow the manufacturer's instructions for handling and disposal.
Safety Advice

AlcoholAlcohol CONSULT YOUR DOCTOR

Avoid or limit alcohol consumption during treatment. Consult your doctor, especially if you experience dizziness, fatigue or other side effects.

PregnancyPregnancy CONSULT YOUR DOCTOR

Tecvayli may cause harm to an unborn baby. Women of reproductive potential should use effective contraception during treatment and for 5 months after the last dose.

BreastfeedingBreastfeeding CONSULT YOUR DOCTOR

Breastfeeding is not recommended during treatment and for 5 months after the last dose because of the potential risk to the infant.

DrivingDriving CONSULT YOUR DOCTOR

Avoid driving or operating machinery if you experience dizziness, fatigue, confusion or neurological symptoms. Tecvayli can cause serious neurological side effects.

KidneyKidney CAUTION

Inform your doctor if you have kidney problems. Kidney function should be monitored, particularly if you develop dehydration or serious infections.

LiverLiver CAUTION

Inform your doctor about any existing liver disease. Liver function should be monitored during treatment, as liver enzyme abnormalities may occur.

Quick Tips
  • Receive Tecvayli injections only under the supervision of a qualified healthcare professional.
  • Follow the prescribed step-up dosing schedule and attend all monitoring appointments.
  • Report fever, chills, cough or other signs of infection to your doctor immediately.
  • Seek urgent medical attention for confusion, difficulty speaking, seizures or breathing difficulties.
  • Use effective contraception during treatment and for 5 months after the last dose.
  • Read More About - Tecvayli (Teclistamab) from Pharma Five.
About Pharma Five

Pharma Five assists patients in facilitating the import of limited quantities of Tecvayli (Teclistamab) for personal medical use, subject to applicable government regulations and import requirements. A valid prescription from a registered medical practitioner, Form 12A and other supporting documents may be required, depending on the applicable regulations.

With over 20 years of experience in the pharmaceutical industry, Pharma Five provides pharmaceutical consultancy and import assistance. We help patients understand the documentation and procedures involved in accessing Tecvayli (Teclistamab) for personal medical use. Pharma Five provides extensive pharmaceutical service coverage across India, serving patients and healthcare requirements in prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

References
  1. https://go.drugbank.com/drugs/DB16655
  2. https://www.ema.europa.eu/en/documents/product-information/tecvayli-epar-product-information_en.pdf
  3. https://www.cancer.gov/about-cancer/treatment/drugs/teclistamab-cqyv
  4. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?audience=professional&setid=54e0f974-ccee-44ea-9254-40e9883cee1e
Faq

General Question

Tecvayli (Teclistamab) is a prescription immunotherapy medicine used to treat adults with relapsed or refractory multiple myeloma. It is a bispecific antibody that helps the immune system recognise and destroy cancer cells.

Tecvayli binds to BCMA on multiple myeloma cells and CD3 on T cells. This brings the two cells together and activates T cells to attack and destroy cancer cells.

Tecvayli is prescribed for eligible adults with relapsed or refractory multiple myeloma. Treatment eligibility depends on the approved indication in the country and the patient’s previous treatments and medical condition.

Tecvayli is administered as a subcutaneous injection by a qualified healthcare professional. Treatment starts with step-up doses followed by a maintenance schedule prescribed by the oncologist.

Common side effects include fever, cytokine release syndrome, muscle and bone pain, injection site reactions, fatigue, upper respiratory tract infections, nausea, headache, pneumonia and diarrhoea.

Yes. Serious side effects may include severe cytokine release syndrome, neurological toxicity such as ICANS, serious infections, low blood cell counts and liver problems. Seek immediate medical attention for severe or unusual symptoms.

Treatment duration depends on the patient’s response, tolerability and the oncologist’s treatment plan. Tecvayli is generally continued until disease progression or unacceptable toxicity, according to the prescribed regimen.

Alcohol consumption should be discussed with your oncologist. Avoid or limit alcohol, particularly if you experience dizziness, fatigue or other treatment-related complications.

Tecvayli may cause harm to an unborn baby. Women of reproductive potential should use effective contraception during treatment and for 5 months after the last dose.

Yes. Always inform your doctor about all prescription medicines, over-the-counter products, vitamins and herbal supplements. Your healthcare team should review possible interactions and treatment-related risks.

Contact your oncology team for instructions if you miss a scheduled injection or appointment. Do not receive an extra dose or change the dosing schedule yourself.

Food does not directly affect Tecvayli because it is administered as an injection under the skin rather than taken orally. Follow your healthcare provider’s dietary recommendations.

Attend all scheduled appointments and monitoring visits. Report fever, signs of infection, confusion, difficulty speaking, breathing problems or other unusual symptoms immediately.

Store Tecvayli in a refrigerator at 2°C to 8°C in its original carton to protect it from light. Do not freeze or shake the medicine.

Pharma Five may assist with information and import facilitation for personal medical use, subject to applicable regulations and required documentation. A valid prescription and supporting documents may be required. Pharma Five assists in its procurement.

Timely Service
Doorstep Delivery
Hassle-Free Process
100% Genuine Sources